Accolades
Success can be measured in many ways, including steady growth in sales and workforce.
By consistently achieving such growth in recent years, Forest has garnered recognition
from our industry and the business world. We are honored to receive such acknowledgment.
View Accolades
- Rated among the top 3 biopharmaceutical companies to work with in a 2013 Global Investigative Site Relationship survey (CenterWatch)
- Ranked #2 of the 25 Best Manufacturing Companies to Sell For Now (Selling
Power, 2012)
- Awarded the Long Island Business Development Council’s Long Island Targeted
Industry Award 2012
- Ranked #1 of the 25 Best Manufacturing Companies to Sell For (Selling
Power, 2011)
- Ranked #3 of the 25 Best Manufacturing Companies to Sell For (Selling
Power, 2010)
- One of the 50 best fertility-friendly and adoption-friendly workplaces in
America (Conceive Magazine, Summer 2010)
- One of the Top 15 U.S.-based Pharma Companies and among the top 50 globally
(Pharmaceutical Executive, May 2010)
- Ranked #3 of the 25 Best Manufacturing Companies to Sell For (Selling
Power, 2009)
- One of the Top 20 U.S.-based Pharma Companies and among the top 50 globally
(Pharmaceutical Executive, May 2009)
- Ranked among the Top 20 Pharma Companies (Medical Marketing & Media,
May 2009)
- One of the 50 best fertility-friendly and adoption-friendly workplaces in
America (Conceive Magazine, May/June 2009)
- Received the Healthcare Distribution Management Association’s 2008 DIANA
Award for Best New Pharmaceutical Product Introduction and/or Product Promotion
for Bystolic® (nebivolol)
- Ranked #3 of the 25 Best Manufacturing Companies to Sell For (Selling
Power, 2008)
- Ranked #6 among top pharmaceutical and biotech companies in Pharmaceutical
Executive’s annual strategic industry audit (September 2008)
- One of the Top 15 U.S. Pharma Companies and among the top 50 globally
(Pharmaceutical Executive, May 2008)
- One of the 50 best fertility-friendly and adoption-friendly workplaces
in America (Conceive Magazine, February 2008)
- Ranked #3 among top pharmaceutical and biotech companies in Pharmaceutical
Executive’s annual strategic industry audit (September 2007)
- One of the Top 15 U.S. Pharma Companies and among the top 50 globally
(Pharmaceutical Executive, May 2007)
- One of the 20 Best Manufacturing Companies to Sell For, seven consecutive
years (Selling Power, 2001-2007)
- Ranked third in the Pharmaceutical Executive’s fifth annual industry
audit which analyzes financial performance of the top pharmaceutical and
biotech companies publicly traded on stock exchanges (September 2006)
- Ranked #27, up from #29, in the Pharmaceutical
Executive's list of the top 50 pharmaceutical companies (May 2006)
- Named an organic "Growth Champion" in Mercer Delta Consulting’s
study, "In Search of Growth: 10 Practices that Create Organic Growth Champions"
(October 10, 2005)
- Campral®(acamprosate calcium) brand team receives Product
Management Today’s Bronze Award for the product’s 2005 launch (October
2005)
- Pharmaceutical Executive names Forest as one of the
Fab Four, joining Genentech, Amgen and Johnson & Johnson in the publication's
2004 audit of the pharmaceutical industry's leading companies (September 2005)
- Ranked #29, up from #32, in the Pharmaceutical Executive's list
of the top 50 pharmaceutical companies (May 2005)
- Ranked as one of The Best Companies to Sell For by
Selling Power
- Appeared on the Forbes 500 list
- Namenda® (memantine HCl) brand team received Product
Management Today's Honorable Mention for the product's 2004 launch
(October 2004)
- Named one of the Top 50 Manufacturing Companies (Industry Week,
August 1, 2004)
- Ranked #5 among the Best Performers of the S&P 500 (BusinessWeek,
April 5, 2004)
- Ranked among the Forbes Platinum list of the 400 best
big companies in America, with special recognition as the best managed company in
the drug and biotechnology industry for 2004 (January 12, 2004)
- The Namenda patient starter kit placed as first runner up in the 2004 Compliance
Package of the Year contest (Healthcare Compliance Packaging Council)
- Recipient of Frost & Sullivan’s 2004 Company of the Year Award
(Neurology category) and Growth Strategy Leadership of the Year Award (Psychiatric
Therapeutics category)
- Ranked as one of The Best Companies to Sell For by
Selling Power
- Ranked among Fortune's Fastest Growing Companies
- Ranked 32nd up from 38th, in Pharmaceutical Executive's list of
the top 50 pharmaceutical companies
- Lexapro® (escitalopram oxalate) brand team named co-Marketing
Team of the Year (2003) by Medical Marketing & Media (December
2003)
- Pharmaceutical Executive names Forest as one of the Fab Four,
joining Pfizer, Johnson & Johnson, and GlaxoSmithKline in the publication's
annual audit of the pharmaceutical industry's leading companies (September 1, 2003)
- Ranked #1 among the Best Performers of the S&P 500 (BusinessWeek,
Spring 2003)
- Ranked as one of The Best Companies to Sell For by
Selling Power
- Ranked among Fortune's Fastest Growing Companies
- Ranked 38th up from 40th, in Pharmaceutical Executive's list of
the top 50 pharmaceutical companies
- Recipient of the National Wholesale Druggists' Association's 2003
DIANA Award for Best New Product Introduction for Lexapro
- Named to the 2003 Forbes A-List, a ranking of the finest
large corporations in the world
- Ranked in the top half of the Forbes Global 2000, a comprehensive
list of the world's biggest companies
- Ranked #1 on the Wall Street Journal Honor Roll
- Ranked in top 100 of the top NYC companies (Newsday)
- Named Technology MVP by BusinessLI
- Appeared on the Forbes 500 list
- Ranked as one of The Best Companies to Sell For by
Selling Power
- Ranked among Fortune's Fastest Growing Companies
- Ranked #3 in Pharmaceutical Executive's list of the fastest growing
pharmaceutical companies
- Ranked 40th in Pharmaceutical Executive's list of the top 50 pharmaceutical
companies
- Appeared on the Forbes 500 list
- Ranked as one of The Best Companies to Sell For by
Selling Power
- Ranked among Fortune's Fastest Growing Companies
- Ranked 40th in Pharmaceutical Executive's list of the top 50 pharmaceutical
companies
- Appeared on the Forbes 500 list
- Ranked among Fortune's Fastest Growing Companies
- Fortune magazine named Howard Solomon, Chairman and CEO,
one of America's Most Powerful People
- Appeared on the Forbes 500 list
